Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991 Aug;84(8):500–501. doi: 10.1177/014107689108400819

Neuroleptic malignant syndrome: a diagnostic dilemma.

S M Sagar 1
PMCID: PMC1293386  PMID: 1886124

Full text

PDF
500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott R. J., Loizou L. A. Neuroleptic malignant syndrome. Br J Psychiatry. 1986 Jan;148:47–51. doi: 10.1192/bjp.148.1.47. [DOI] [PubMed] [Google Scholar]
  2. Adityanjee, Singh S., Singh G., Ong S. Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry. 1988 Jul;153:107–111. doi: 10.1192/bjp.153.1.107. [DOI] [PubMed] [Google Scholar]
  3. Caroff S. N. The neuroleptic malignant syndrome. J Clin Psychiatry. 1980 Mar;41(3):79–83. [PubMed] [Google Scholar]
  4. Castillo E., Rubin R. T., Holsboer-Trachsler E. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry. 1989 Mar;146(3):324–328. doi: 10.1176/ajp.146.3.324. [DOI] [PubMed] [Google Scholar]
  5. Coons D. J., Hillman F. J., Marshall R. W. Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report. Am J Psychiatry. 1982 Jul;139(7):944–945. doi: 10.1176/ajp.139.7.944. [DOI] [PubMed] [Google Scholar]
  6. Fleischhacker W. W., Unterweger B., Kane J. M., Hinterhuber H. The neuroleptic malignant syndrome and its differentiation from lethal catatonia. Acta Psychiatr Scand. 1990 Jan;81(1):3–5. doi: 10.1111/j.1600-0447.1990.tb06439.x. [DOI] [PubMed] [Google Scholar]
  7. Harland C. C., O'Leary M. M., Winters R., Owens J., Hayes B., Melikian V. Neuroleptic malignant syndrome: a case for electroconvulsive therapy. Postgrad Med J. 1990 Jan;66(771):49–51. doi: 10.1136/pgmj.66.771.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kellam A. M. The neuroleptic malignant syndrome, so-called. A survey of the world literature. Br J Psychiatry. 1987 Jun;150:752–759. doi: 10.1192/bjp.150.6.752. [DOI] [PubMed] [Google Scholar]
  9. Mueller P. S., Vester J. W., Fermaglich J. Neuroleptic malignant syndrome. Successful treatment with bromocriptine. JAMA. 1983 Jan 21;249(3):386–388. [PubMed] [Google Scholar]
  10. O'Neill W. M. The neuroleptic malignant syndrome. Clin Oncol (R Coll Radiol) 1990 Jul;2(4):241–242. doi: 10.1016/s0936-6555(05)80176-1. [DOI] [PubMed] [Google Scholar]
  11. Rosenberg M. R., Green M. Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med. 1989 Sep;149(9):1927–1931. doi: 10.1001/archinte.149.9.1927. [DOI] [PubMed] [Google Scholar]
  12. Stoudemire A., Luther J. S. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. Int J Psychiatry Med. 1984;14(1):57–63. doi: 10.2190/lxd2-jtxj-3lpq-9pdn. [DOI] [PubMed] [Google Scholar]
  13. Szabadi E. Neuroleptic malignant syndrome. Br Med J (Clin Res Ed) 1984 May 12;288(6428):1399–1400. doi: 10.1136/bmj.288.6428.1399-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Velamoor V. R., Fernando M. L., Williamson P. Incipient neuroleptic malignant syndrome? Br J Psychiatry. 1990 Apr;156:581–584. doi: 10.1192/bjp.156.4.581. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES